Literature DB >> 19269855

The risk of dying from lung cancer by race: a prospective cohort study in a biracial cohort in Charleston, South Carolina.

Jill M Nonemaker1, Elizabeth Garrett-Mayer, Matthew J Carpenter, Marvella E Ford, Gerard Silvestri, Daniel T Lackland, Anthony J Alberg.   

Abstract

PURPOSE: Compared to European Americans (EAs), African Americans (AAs) suffer a disproportionate share of the lung cancer mortality burden. To investigate whether this disparity in lung cancer mortality is due to differential racial risks related to socioeconomic status (education, occupation), body mass index (BMI), hypertension, or cigarette smoking, we compared associations between these factors and lung cancer mortality by race in a biracial prospective cohort study.
METHODS: The Charleston (South Carolina) Heart Study (N = 2,054) was established in 1960; 40% of the study participants are AAs. The participants have been followed up for mortality for 40 years. Using Cox proportional hazards models, we investigated whether there were racial differences in the associations between the study factors and lung cancer mortality.
RESULTS: Cigarette smoking was the strongest lung cancer risk factor in both races. The association between cigarette smoking and lung cancer mortality was stronger in EAs than AAs (hazards ratio [HR] 26.1 vs. 7.6). In both races, men were at significantly greater risk than women and BMI was significantly inversely associated with lung cancer mortality.
CONCLUSIONS: The evidence from the present study does not yield strong clues for the excess lung cancer mortality in AAs. Our results do not support the hypothesis that differential susceptibility to cigarette smoking is a major contributor to the racial disparity in lung cancer. This suggests we must expand our scope of inquiry beyond the factors included in the present study to fully understand why lung cancer mortality rates are greater in AAs than EAs.

Entities:  

Mesh:

Year:  2009        PMID: 19269855     DOI: 10.1016/j.annepidem.2008.12.017

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  8 in total

1.  Body mass index and mortality in lung cancer patients: a systematic review and meta-analysis.

Authors:  J Wang; H Xu; S Zhou; D Wang; L Zhu; J Hou; J Tang; J Zhao; S Zhong
Journal:  Eur J Clin Nutr       Date:  2017-05-17       Impact factor: 4.016

2.  Obesity and weight loss at presentation of lung cancer are associated with opposite effects on survival.

Authors:  Relin Yang; Michael C Cheung; Felipe E Pedroso; Margaret M Byrne; Leonidas G Koniaris; Teresa A Zimmers
Journal:  J Surg Res       Date:  2011-05-23       Impact factor: 2.192

3.  The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett's Esophagus and Esophageal Adenocarcinoma Consortium.

Authors:  Jay H Lubin; Michael B Cook; Nirmala Pandeya; Thomas L Vaughan; Christian C Abnet; Carol Giffen; Penelope M Webb; Liam J Murray; Alan G Casson; Harvey A Risch; Weimin Ye; Farin Kamangar; Leslie Bernstein; Linda Sharp; Olof Nyrén; Marilie D Gammon; Douglas A Corley; Anna H Wu; Linda M Brown; Wong-Ho Chow; Mary H Ward; Neal D Freedman; David C Whiteman
Journal:  Cancer Epidemiol       Date:  2012-04-13       Impact factor: 2.984

4.  Cigarette warning label policy alternatives and smoking-related health disparities.

Authors:  James F Thrasher; Matthew J Carpenter; Jeannette O Andrews; Kevin M Gray; Anthony J Alberg; Ashley Navarro; Daniela B Friedman; K Michael Cummings
Journal:  Am J Prev Med       Date:  2012-12       Impact factor: 5.043

5.  Respiratory disease mortality among US coal miners; results after 37 years of follow-up.

Authors:  Judith M Graber; Leslie T Stayner; Robert A Cohen; Lorraine M Conroy; Michael D Attfield
Journal:  Occup Environ Med       Date:  2013-11-01       Impact factor: 4.402

6.  Associations between body mass index and the risk of mortality from lung cancer: A dose-response PRISMA-compliant meta-analysis of prospective cohort studies.

Authors:  Ning Shen; Ping Fu; Bin Cui; Chun-Ying Bu; Jing-Wang Bi
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

7.  Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation.

Authors:  Alessio Cortellini; Biagio Ricciuti; Marcello Tiseo; Emilio Bria; Giuseppe L Banna; Joachim Gjv Aerts; Fausto Barbieri; Raffaele Giusti; Diego L Cortinovis; Maria R Migliorino; Annamaria Catino; Francesco Passiglia; Mariangela Torniai; Alessandro Morabito; Carlo Genova; Francesca Mazzoni; Vincenzo Di Noia; Diego Signorelli; Alain Gelibter; Mario Alberto Occhipinti; Francesca Rastelli; Rita Chiari; Danilo Rocco; Alessandro Inno; Michele De Tursi; Pietro Di Marino; Giovanni Mansueto; Federica Zoratto; Francesco Grossi; Marco Filetti; Pamela Pizzutilo; Marco Russano; Fabrizio Citarella; Luca Cantini; Giada Targato; Olga Nigro; Miriam G Ferrara; Sebastiano Buti; Simona Scodes; Lorenza Landi; Giorgia Guaitoli; Luigi Della Gravara; Fabrizio Tabbò; Serena Ricciardi; Alessandro De Toma; Alex Friedlaender; Fausto Petrelli; Alfredo Addeo; Giampiero Porzio; Corrado Ficorella
Journal:  J Immunother Cancer       Date:  2020-10       Impact factor: 13.751

8.  Association of Obesity With Survival Outcomes in Patients With Cancer: A Systematic Review and Meta-analysis.

Authors:  Fausto Petrelli; Alessio Cortellini; Alice Indini; Gianluca Tomasello; Michele Ghidini; Olga Nigro; Massimiliano Salati; Lorenzo Dottorini; Alessandro Iaculli; Antonio Varricchio; Valentina Rampulla; Sandro Barni; Mary Cabiddu; Antonio Bossi; Antonio Ghidini; Alberto Zaniboni
Journal:  JAMA Netw Open       Date:  2021-03-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.